Theragene Pharmaceuticals Company

Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.


Investors

Total Funding: 548000
Headquarters: San Diego, California, United States
Funding Status: Early Stage Venture
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Last Funding Type: Convertible Note
Technology: Cancer
Investor Type: Early Stage Venture
Last Funding Date: 2017
Investors Number: 1
Founded Date: 2011
Industry: Biotechnology, Pharmaceutical, Therapeutics